Moderna Says Flu-Covid Vaccine Succeeds in Early-Stage Trial
The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.
Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday.
By Josh Beckerman Shares of Nuvalent hit a 52-week high and were recently up 30% after the company reported favorable preliminary data from a clinical trial...
Board agrees to review patent covering certain strengths of blockbuster diabetes drug
By Will Feuer Shares of ALX Oncology jumped after the developer of potential cancer treatments reported an interim analysis of early data from its Phase 2...